Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204].

Autor: Alkhunaizi M; Department of Medicine, Baylor College of Medicine, Houston, Texas., Patel B; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Bueno L; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico., Bhan N; Department of Medicine, Baylor College of Medicine, Houston, Texas., Ahmed T; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Arain MH; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Saliba R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dickey BF; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bashoura L; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ost DE; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mehta R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: asheshadri@mdanderson.org.
Jazyk: angličtina
Zdroj: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov 17. Date of Electronic Publication: 2024 Nov 17.
DOI: 10.1016/j.jtct.2024.10.013
Databáze: MEDLINE